Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

TIME TRENDS IN ADHERENCE TO SURVEILLANCE INTERVALS AND BIOPSY PROTOCOL AMONG PATIENTS WITH BARRETT'S ESOPHAGUS.

Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ.

Gastroenterology. 2019 Oct 14. pii: S0016-5085(19)41438-8. doi: 10.1053/j.gastro.2019.10.004. [Epub ahead of print] No abstract available.

PMID:
31622626
2.

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-blind, Double-dummy Trial.

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, Gebhart JH, Galanko JA, Baron JA, Shaheen NJ.

Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30972-3. doi: 10.1016/j.cgh.2019.08.050. [Epub ahead of print]

PMID:
31499249
3.

Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.

Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB.

Cancer. 2019 Sep 6. doi: 10.1002/cncr.32444. [Epub ahead of print]

PMID:
31490550
4.

Random biopsy of the neosquamous epithelium is a waste of time and money.

Tan WK, Shaheen NJ.

Gastrointest Endosc. 2019 Sep;90(3):404-406. doi: 10.1016/j.gie.2019.05.008. No abstract available.

PMID:
31439129
5.

Management of Barrett Esophagus Following Radiofrequency Ablation.

Reed CC, Shaheen NJ.

Gastroenterol Hepatol (N Y). 2019 Jul;15(7):377-386.

6.

Heartburn and dyspepsia symptom severity improves after treatment and correlates with histology in adults with eosinophilic esophagitis.

Eluri S, Perjar I, Betancourt R, Randall C, Raja S, Woosley JT, Shaheen NJ, Dellon ES.

Dis Esophagus. 2019 Apr 25. pii: doz028. doi: 10.1093/dote/doz028. [Epub ahead of print]

PMID:
31329864
7.

Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort.

Song KY, Henn AJ, Gravely AA, Mesa H, Sultan S, Shaheen NJ, Shaukat A, Hanson BJ.

Dis Esophagus. 2019 Jul 5. pii: doz061. doi: 10.1093/dote/doz061. [Epub ahead of print]

PMID:
31274147
8.

Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species.

Thompson CG, Rosen EP, Prince HMA, White N, Sykes C, de la Cruz G, Mathews M, Deleage C, Estes JD, Charlins P, Mulder LR, Kovarova M, Adamson L, Arora S, Dellon ES, Peery AF, Shaheen NJ, Gay C, Muddiman DC, Akkina R, Garcia JV, Luciw P, Kashuba ADM.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaap8758. doi: 10.1126/scitranslmed.aap8758.

PMID:
31270274
9.

Barrett oesophagus.

Peters Y, Al-Kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD.

Nat Rev Dis Primers. 2019 May 23;5(1):35. doi: 10.1038/s41572-019-0086-z. Review.

PMID:
31123267
10.

Endoscopists systematically undersample patients with long-segment Barrett's esophagus: an analysis of biopsy sampling practices from a quality improvement registry.

Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ.

Gastrointest Endosc. 2019 Nov;90(5):732-741.e3. doi: 10.1016/j.gie.2019.04.250. Epub 2019 May 11.

PMID:
31085185
11.

Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy.

Eluri S, Earasi AG, Moist SE, Dellon ES, Shaheen NJ.

Clin Gastroenterol Hepatol. 2019 May 8. pii: S1542-3565(19)30497-5. doi: 10.1016/j.cgh.2019.04.065. [Epub ahead of print]

PMID:
31077822
12.

Durability of Endoscopic Treatment for Dysplastic Barrett's Esophagus.

Reed CC, Shaheen NJ.

Curr Treat Options Gastroenterol. 2019 Jun;17(2):171-186. doi: 10.1007/s11938-019-00226-5. Review.

PMID:
31077058
13.

Where is the finish line for endoscopic eradication therapy in Barrett's esophagus?

Shaheen NJ.

Gastrointest Endosc. 2019 May;89(5):926-928. doi: 10.1016/j.gie.2019.01.017. No abstract available.

PMID:
31005132
14.

Combination Therapy with Elimination Diet and Corticosteroids is Effective for Adults with Eosinophilic Esophagitis.

Reed CC, Tappata M, Eluri S, Shaheen NJ, Dellon ES.

Clin Gastroenterol Hepatol. 2019 Mar 15. pii: S1542-3565(19)30273-3. doi: 10.1016/j.cgh.2019.03.009. [Epub ahead of print]

PMID:
30885887
15.

Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis.

Parasa S, Desai M, Vittal A, Chandrasekar VT, Pervez A, Kennedy KF, Gupta N, Shaheen NJ, Sharma P.

Gut. 2019 Mar 14. pii: gutjnl-2018-317800. doi: 10.1136/gutjnl-2018-317800. [Epub ahead of print]

PMID:
30872393
16.

Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, Gebhart JH, Tylicki AE, Shoyoye SO, Martin CF, Galanko JA, Baron JA, Shaheen NJ.

Gastroenterology. 2019 Jul;157(1):65-73.e5. doi: 10.1053/j.gastro.2019.03.014. Epub 2019 Mar 11.

PMID:
30872104
17.

Over-Utilization of Repeat Upper Endoscopy in Patients with Non-dysplastic Barrett's Esophagus: A Quality Registry Study.

Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ.

Am J Gastroenterol. 2019 Aug;114(8):1256-1264. doi: 10.14309/ajg.0000000000000184.

PMID:
30865017
18.

Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.

Blum AE, Venkitachalam S, Ravillah D, Chelluboyina AK, Kieber-Emmons AM, Ravi L, Kresak A, Chandar AK, Markowitz SD, Canto MI, Wang JS, Shaheen NJ, Guo Y, Shyr Y, Willis JE, Chak A, Varadan V, Guda K.

Gastroenterology. 2019 May;156(6):1761-1774. doi: 10.1053/j.gastro.2019.01.263. Epub 2019 Feb 12.

PMID:
30768984
19.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1.

PMID:
30716477
20.

What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?

Ramay FH, Vareedayah AA, Visrodia K, Iyer PG, Wang KK, Eluri S, Shaheen NJ, Reddy R, Martin LW, Greenwald BD, Edwards MA.

Ann Surg Oncol. 2019 Mar;26(3):714-731. doi: 10.1245/s10434-018-07118-5. Epub 2019 Jan 3. Review.

PMID:
30607765
21.

Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.

Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI, Shaheen NJ, Kresty LA, Chak A, Wang TD, Rubenstein JH, Beer DG.

Gastroenterology. 2019 Apr;156(5):1404-1415. doi: 10.1053/j.gastro.2018.12.004. Epub 2018 Dec 19.

PMID:
30578782
22.

A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.

Duits LC, Lao-Sirieix P, Wolf WA, O'Donovan M, Galeano-Dalmau N, Meijer SL, Offerhaus GJA, Redman J, Crawte J, Zeki S, Pouw RE, Chak A, Shaheen NJ, Bergman JJGHM, Fitzgerald RC.

Dis Esophagus. 2019 Jan 1;32(1). doi: 10.1093/dote/doy102.

PMID:
30496496
23.

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS.

Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10. Review. Erratum in: Gastroenterology. 2019 May;156(6):1936.

PMID:
30315778
24.

How to Promote the Academic Success of Junior Faculty Physicians in Gastroenterology.

Shaheen NJ, Sandler RS.

Gastroenterology. 2018 Nov;155(5):1293-1297. doi: 10.1053/j.gastro.2018.10.006. Epub 2018 Oct 6. No abstract available.

PMID:
30300615
25.

A prospective multicenter study using a new multiband mucosectomy device for endoscopic resection of early neoplasia in Barrett's esophagus.

Pouw RE, Beyna T, Belghazi K, Koch AD, Schoon EJ, Haidry R, Weusten BL, Bisschops R, Shaheen NJ, Wallace MB, Marcon N, Heise-Ginsburg R, Gotink AW, Wang KK, Leggett CL, Ortiz-Fernández-Sordo J, Ragunath K, DiPietro M, Pech O, Neuhaus H, Bergman JJ.

Gastrointest Endosc. 2018 Oct;88(4):647-654. doi: 10.1016/j.gie.2018.06.030. Epub 2018 Jul 6.

PMID:
30220300
26.

Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.

Eluri S, Selitsky SR, Perjar I, Hollyfield J, Betancourt R, Randall C, Rusin S, Woosley JT, Shaheen NJ, Dellon ES.

Clin Gastroenterol Hepatol. 2019 May;17(6):1081-1088.e2. doi: 10.1016/j.cgh.2018.09.005. Epub 2018 Sep 10.

PMID:
30213583
27.

A Survey of Expert Practice and Attitudes Regarding Advanced Imaging Modalities in Surveillance of Barrett's Esophagus.

Machicado JD, Han S, Yadlapati RH, Simon VC, Qumseya BJ, Sultan S, Kushnir VM, Komanduri S, Rastogi A, Muthusamy VR, Haidry R, Ragunath K, Singh R, Hammad HT, Shaheen NJ, Wani S.

Dig Dis Sci. 2018 Dec;63(12):3262-3271. doi: 10.1007/s10620-018-5257-3. Epub 2018 Sep 3.

PMID:
30178283
28.

Dysplasia severity is associated with poor quality of life in patients with Barrett's esophagus referred for endoscopic eradication therapy.

Han S, Yadlapati R, Simon V, Ezekwe E, Early DS, Kushnir V, Hollander T, Brauer BC, Hammad H, Edmundowicz SA, Wood M, Shaheen NJ, Muthusamy RV, Komanduri S, Wani S.

Dis Esophagus. 2019 Jan 1;32(1). doi: 10.1093/dote/doy086.

29.

Endoscopic Management of Barrett Esophagus.

Shaheen NJ.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):433-435. No abstract available.

30.

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients.

Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):647-656.e1. doi: 10.1016/j.cgh.2018.07.043. Epub 2018 Aug 9.

31.

WATS for Barrett's surveillance.

Goldblum JR, Shaheen NJ, Vennalaganti PR, Sharma P, Lightdale CJ.

Gastrointest Endosc. 2018 Jul;88(1):201-202. doi: 10.1016/j.gie.2018.01.038. No abstract available.

PMID:
29935618
32.

Higher Rate of Barrett's Detection in the First Year After Successful Endoscopic Therapy: Meta-analysis.

Sawas T, Iyer PG, Alsawas M, Cotton CC, Leggett CL, Murad MH, Wang KK, Shaheen NJ, Katzka DA.

Am J Gastroenterol. 2018 Jul;113(7):959-971. doi: 10.1038/s41395-018-0090-z. Epub 2018 Jun 14.

PMID:
29899439
33.

Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP.

Am J Gastroenterol. 2018 Aug;113(8):1148-1155. doi: 10.1038/s41395-018-0070-3. Epub 2018 Jun 8.

PMID:
29880962
34.

Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and women.

Weber MD, Andrews E, Prince HA, Sykes C, Rosen EP, Bay C, Shaheen NJ, Madanick RD, Dellon ES, De Paris K, Nelson JA, Gay CL, Kashuba AD.

Antivir Ther. 2018;23(6):495-504. doi: 10.3851/IMP3236.

PMID:
29714167
35.

Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.

Yadlapati R, Vaezi MF, Vela MF, Spechler SJ, Shaheen NJ, Richter J, Lacy BE, Katzka D, Katz PO, Kahrilas PJ, Gyawali PC, Gerson L, Fass R, Castell DO, Craft J, Hillman L, Pandolfino JE.

Am J Gastroenterol. 2018 Jul;113(7):980-986. doi: 10.1038/s41395-018-0045-4. Epub 2018 Apr 24.

36.

Natural History of the Post-ablation Esophagus.

Reed CC, Shaheen NJ.

Dig Dis Sci. 2018 Aug;63(8):2136-2145. doi: 10.1007/s10620-018-5066-8. Review.

PMID:
29671157
37.

Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.

Cotton CC, Haidry R, Thrift AP, Lovat L, Shaheen NJ.

Gastroenterology. 2018 Aug;155(2):316-326.e6. doi: 10.1053/j.gastro.2018.04.011. Epub 2018 Apr 13.

38.

Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma.

Eluri S, Klaver E, Duits LC, Jackson SA, Bergman JJ, Shaheen NJ.

Dis Esophagus. 2018 Nov 1;31(11). doi: 10.1093/dote/doy026.

39.

Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video).

Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ.

Gastrointest Endosc. 2018 Sep;88(3):438-446.e2. doi: 10.1016/j.gie.2018.03.024. Epub 2018 Apr 5.

40.

Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course.

Shaheen NJ, Mukkada V, Eichinger CS, Schofield H, Todorova L, Falk GW.

Dis Esophagus. 2018 Aug 1;31(8). doi: 10.1093/dote/doy015.

41.

Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis.

Reed CC, Fan C, Koutlas N, Stefanadis Z, Eluri S, Shaheen NJ, Dellon ES.

HSOA J Gastroenterol Hepatol Res. 2018;7(1):2509-2515. Epub 2018 Feb 21.

42.

Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) Consortium, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1598-1606.e4. doi: 10.1016/j.cgh.2018.03.007. Epub 2018 Mar 15.

43.

Association of sporadic and familial Barrett's esophagus with breast cancer.

Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/doy007.

44.

IMportance of an Irregular Z Line: Is Barrett's in the Eye of the Beholder?

Eluri S, Shaheen NJ.

Dig Dis Sci. 2018 Jun;63(6):1378-1380. doi: 10.1007/s10620-018-4998-3. No abstract available.

PMID:
29492745
45.

The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.

Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG.

Gastroenterology. 2018 Jun;154(8):2068-2086.e5. doi: 10.1053/j.gastro.2018.02.022. Epub 2018 Feb 16. Review.

46.

Less Is More: A Minimalist Approach to Endoscopy.

Shaheen NJ, Fennerty MB, Bergman JJ.

Gastroenterology. 2018 May;154(7):1993-2003. doi: 10.1053/j.gastro.2017.12.044. Epub 2018 Feb 15. Review.

PMID:
29454789
47.

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.

Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaao5848. doi: 10.1126/scitranslmed.aao5848.

48.

Endoscopic Eradication Therapy in Barrett's Esophagus.

Eluri S, Shaheen NJ.

Tech Gastrointest Endosc. 2017 Jul;19(3):137-142. doi: 10.1016/j.tgie.2017.06.001. Epub 2017 Jun 12.

49.

Corrigendum: Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study.

Katzka DA, Smyrk TC, Alexander JA, Geno DM, Beitia RA, Chang AO, Shaheen NJ, Fitzgerald RC, Dellon ES.

Am J Gastroenterol. 2018 Feb;113(2):310. doi: 10.1038/ajg.2017.474. Epub 2017 Dec 19.

PMID:
29257149
50.

Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.

Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) consortium, Whiteman DC, Vaughan TL, Thrift AP.

Gastroenterology. 2018 Apr;154(5):1273-1281.e3. doi: 10.1053/j.gastro.2017.12.003. Epub 2017 Dec 13.

Supplemental Content

Loading ...
Support Center